Insurance Journal  Jul 6  Comment 
Oklahoma Attorney General Mike Hunter has joined the ranks of state attorneys general who have sued manufacturers of opioid pain medication, alleging that deceptive marketing campaigns by the drug makers have fueled the state’s opioid epidemic....
Motley Fool  Jun 28  Comment 
Can AbbVie's top-notch clinical pipeline overcome the company's hefty risk profile?
Insurance Journal  Jun 23  Comment 
Missouri on June 21 became the third U.S. state to accuse major drug manufacturers of fraudulently misrepresenting the risks of opioid painkillers now at the center of a national addiction epidemic. Missouri Attorney General Josh Hawley said his...
Insurance Journal  Jun 19  Comment 
A new lawsuit invokes the plight of a baby born dependent on opioid drugs, as three Tennessee prosecutors and the baby’s guardian accuse several drug manufacturers of unleashing an epidemic through deceptive marketing about the risks of...
DailyFinance  Mar 8  Comment 
Filed under: News, Politics, White House President Donald Trump met with Reps. Elijah Cummings and Peter Welch, along with Johns Hopkins president Dr. Redonda Miller, on Wednesday to talk about drug pricing. Under current law, the Secretary...
New York Times  Jan 19  Comment 
We need to change the incentives for drug manufacturers.
Forbes  Jan 11  Comment 
A day of reckoning could be coming for drug manufacturers.
Wall Street Journal  Oct 7  Comment 
Insulin prices are soaring, creating pain for patients whose life depends on the injectable drug—yet most of the revenue from the increases isn’t going to the drug manufacturers, it is largely being collected by the middlemen.
The Economic Times  May 10  Comment 
"We have not terminated their licence, but have asked the manufacturers to fulfill the conditions and then will restore their production," the government said.
Benzinga  Mar 7  Comment 
BTIG’s Timothy Chiang mentioned that shares of specialty pharmaceutical companies are down 20 percent year-to-date, as compared to a 5.8 percent decline in the S&P 500. The decline is largely attributable to investor concerns surrounding the...

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki